13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q1 2023 · Filed February 8, 2023 · Accession 0000950123-23-001109
Total Value
$74.4M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Dyne Therapeutics, Inc. | DYN | 2,220,034 | $25.7M | 34.58% |
| 2 | Kinnate Biopharma, Inc. | 49705R105 | 2,207,772 | $13.5M | 18.10% |
| 3 | Centessa Pharmaceuticals plc | CNTA | 3,931,818 | $12.2M | 16.38% |
| 4 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $11.3M | 15.20% |
| 5 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $4.5M | 6.02% |
| 6 | LianBio | LIANY | 2,282,084 | $3.7M | 5.03% |
| 7 | Praxis Precision Medicines, Inc. | PRAX | 1,469,665 | $3.5M | 4.70% |